MAOA and Parkinson disease: Using autoradiographic imaging methods, we have evaluated MAO-A activity in postmortem human Parkinson’s disease (PD) brain sections of the anterior cingulate using [18F]FAZIN3, a new reversible MAO-A inhibitor [24].